TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center > Enterprise Dynamic >
Enterprise Dynamic
Brain glioma patent approved

On July 12, 2017, the Company received the Patent Authorization issued by the State Intellectual Property Bureau, which showed that the Company has obtained one more granted invention patent in treating brain glioma, marking a step forward in the treatment and research of brain glioma.

Prev:Clinical Data Release on Chlorogenic Acid for Injection of Class I New Drugs Worldwide
Next:Jiuzhang Biotech Data Presentation on the Phase I Clinical Trial on the Safety, Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Treating Advanced Cerebral Glioma